Skip to content

Insider · CIK 0001329010

Chardonnet Laurent

Reports to the SEC for 3 companies · WILMINGTON, DE

Transactions

50

Companies

3

Filings

15

CIK

0001329010

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2024-03-01PRLDPrelude Therapeutics Inc · Employee Stock Option (right to buy)A Award—
2023-05-23PRLDPrelude Therapeutics IncP Purchase+$27.5K
2023-02-07PRLDPrelude Therapeutics Inc · Employee Stock Option (right to buy)A Award—
2022-12-21PRLDPrelude Therapeutics Inc · Employee Stock Option (right to buy)A Award—
2022-12-08PRLDPrelude Therapeutics IncP Purchase+$47.6K
2022-06-01PRLDPrelude Therapeutics IncP Purchase+$42.3K
2022-03-21PRLDPrelude Therapeutics IncA Award+$48.8K
2022-02-15PRLDPrelude Therapeutics Inc · Employee Stock Option (right to buy)A Award—
2021-12-13PRLDPrelude Therapeutics IncA Award+$61.4K
2021-11-29PRLDPrelude Therapeutics Inc · Employee Stock Option (Right to Buy)A Award—
2021-02-09Axcella Health Inc.Restricted Stock UnitsA Award—
2021-02-09Axcella Health Inc.Stock Option (Right to Buy)A Award—
2021-02-09Axcella Health Inc.Stock Option (Right to Buy)A Award—
2020-10-30Axcella Health Inc.A Award+$9,363.6
2020-01-31Axcella Health Inc.P Purchase+$14.8K
2020-01-27Axcella Health Inc.P Purchase+$1,738.88
2020-01-24Axcella Health Inc.P Purchase+$1,539.96
2019-12-18Axcella Health Inc.Stock Option (Right to Buy)A Award—
2015-03-30INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORP · Incentive Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$489K
2015-03-30INCYINCYTE CORPS Sale−$2.6M
2015-03-30INCYINCYTE CORPS Sale−$3.75M
2015-03-30INCYINCYTE CORP · Incentive Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORPS Sale−$4.31M
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$2,227.78
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$77.8K
2015-03-30INCYINCYTE CORP · Incentive Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$105K
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$484K
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$103K
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$608K
2015-03-30INCYINCYTE CORPM Exercise/Conversion+$20K
2015-03-30INCYINCYTE CORP · Incentive Stock Option (right to buy)M Exercise/Conversion—
2015-03-30INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2015-01-08INCYINCYTE CORP · Incentive Stock Option (right to buy)A Award—
2015-01-08INCYINCYTE CORP · Incentive Stock Option (right to buy)A Award—
2015-01-08INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award—
2015-01-08INCYINCYTE CORPA Award—
2015-01-08INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award—
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$12.1K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$130K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$229K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$106K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$373K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$23.2K
2014-02-13INCYINCYTE CORPM Exercise/Conversion+$34.6K
2014-02-13INCYINCYTE CORPS Sale−$6.52M

Recent filings

15